Vasculitis in the News (RSS News Feeds)
- Dynavax: Looking Ahead To A Long and Tiring Journey – Seeking Alpha
- IL-6 Blocker Wins in Vasculitis – MedPage Today
- Tocolizumab improves remission rates in giant-cell arteritis: The GiACTA trial – 2 Minute Medicine
- Patients with giant cell arteritis faced greater direct care cost due to greater health care use – Healio
- ChemoCentryx to Hold Second Quarter 2017 Financial Results Conference Call on Tuesday, August 8, 2017 – Nasdaq
- ChemoCentryx to Hold Second Quarter 2017 Financial Results Conference Call on Tuesday, August 8, 2017 – GlobeNewswire (press release)
- Vasculitis Drug Market Segments By Product Types, Manufacturers, Regions And Application Analysis To 2021 – MilTech
- Vasculitis Drug Market Segments By Product Types, Manufacturers, Regions And Application Analysis To 2021 – satPRnews (press release)
- Vasculitis Drug Market By Key Players, Growth Factors, Regions And Applications, Industry Forecast By 2021 – satPRnews (press release)
- Caledonia teen’s wish made, fulfilled – Journal Times
- Azithromycin (zithromax) for sale – Zithromax 100mg 5ml – Ashford United FC (press release)
- Worldwide Vasculitis Treatment Market 2017-2021 Consumption, Suppliers, Industry Rivalry, New Entrant with facing … – MilTech
- Worldwide Vasculitis Treatment Market 2017-2021 Consumption, Suppliers, Industry Rivalry, New Entrant with facing … – satPRnews (press release)
- Vasculitis Drug Market Top Manufacturers, Market Driving Factors and Key vendors forecast by 2022 – MilTech
- Vascular dementia second leading cause of memory loss – The Torrington Telegram